- Grant Amount – up to $50,000
- Deadline – September 01, 2025
- CLICK HERE TO APPLY
The Pfizer has launched a competitive program that seeks to bridge this data gap and ultimately benefit public health.
.
Areas of Interest
- Evaluating the pneumococcal burden of disease and serotype distribution post the implementation of PCV immunization programs with PCV
- Invasive Pneumococcal Disease (IPD)
- Community Acquired Pneumonia (CAP)
- Genetic evolution of pneumococci following immunization programs with PCV
- Nasopharyngeal carriage in children in children less than 5 years following the implementation of PCV immunization programs
- Antibiotic resistance of S. pneumoniae in children
- Projects looking reviews and analysis of retrospective invasive pneumococcal disease serotyping data already available from records such as:
- – National- or subnational-level data (including local language data).
- – Publicly available surveillance reports at the national- or subnational- level, which includes hospitals,
- – public health organizations, or academic settings (such as universities or educational institutions).
- – Invasive pneumococcal disease (IPD) clinical presentations to be considered include sepsis/bacteremia, meningitis, or bacteremia pneumonia, as well as other presentations of IPD such as empyema, peritonitis, osteoarticular infection/septic arthritis, endocarditis.
- – The clinical isolates should have been obtained from blood or cerebrospinal fluid (CSF), or from any other normally sterile site no earlier than 2022.
- – Local nasopharyngeal carriage (NP) data and invasive pneumococcal disease (IPD) surveillance data from country settings that are under-represented in the international, peer-reviewed medical literature will be given priority.
- – Further with respect to serotyping of laboratory samples currently under cold storage: Serotyping method could be performed using conventional (Quelling) or molecular (PCR or whole genome sequencing) methods.
Funding Information
- The estimated total available budget for this RFP is $400,000 USD
- Individual projects requesting up to $50,000 USD will be considered.
- For projects requiring third-party lab services for serotyping and the corresponding transportation of samples, up to an additional $30,000 (total $80,000) will be considered.
Geographic Location
- Mozambique, Democratic Republic of Congo, Burkina Faso, Sudan, Ethiopia, Ghana, Tanzania, Senegal, and Cote ’d’Ivoire.
Eligibility:
- Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society).
- If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
- The PI must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
- The applicant must be the PI or an authorized designee of such individual (e.g., PI’s research coordinator).
- The PI must be an employee or contractor of the requesting organization.
- Requesting organization must be legally able to receive award funding directly from Pfizer Inc. They strongly recommend that applicants confirm this with their organization or institution prior to submitting an application. Grants awarded to organizations that are subsequently found to be unable to accept funding directly from Pfizer Inc. may be subject to rescission.
…………………………………………………………………………………………………………..
At Funding Square, we help African entrepreneurs and organizations access funding through three expert services:
.
- Grant Research Service – Get 50 tailored grant opportunities handpicked for your business or nonprofit, saving you time and effort.
- Grant Proposal Writing – We craft compelling, funder-friendly proposals that grab attention and increase your chances of success.
- Fundraising Business Plan – A powerful, funding-ready business plan designed to attract grants, loans, and investors.
Let’s turn your funding goals into reality!
.
Contact us today by sending us an email at hello@fundingsquare.org